Belite Bio BLTE is set to give its latest quarterly earnings report on Tuesday, 2024-11-12. Here's what investors need to know before the announcement.
Analysts estimate that Belite Bio will report an earnings per share (EPS) of $-0.29.
The market awaits Belite Bio's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
Earnings Track Record
During the last quarter, the company reported an EPS missed by $0.01, leading to a 0.0% drop in the share price on the subsequent day.
Here's a look at Belite Bio's past performance and the resulting price change:
| Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| EPS Estimate | -0.25 | -0.28 | -0.30 | |
| EPS Actual | -0.26 | -0.33 | -0.25 | -0.4 |
| Price Change % | 0.0% | 1.0% | -12.0% | -4.0% |
Tracking Belite Bio's Stock Performance
Shares of Belite Bio were trading at $81.08 as of November 08. Over the last 52-week period, shares are up 110.69%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release.
To track all earnings releases for Belite Bio visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
